Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a treatment versus no-treatment control in children with HBeAg-positive chronic hepatitis B
CTR20140077Phase 3Active
- Sponsor
- Roche
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Roche. Started May 2014; status: active.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20140077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140077.